Status:
COMPLETED
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This ...
Detailed Description
OBJECTIVES: * To identify and characterize single nucleotide variations (SNVs) in non-small cell lung cancer (NSCLC) specimens. * To identify and characterize structural variations in the genomes of ...
Eligibility Criteria
Inclusion
- Patient must have been registered to CALGB 140202.
- Tumor histology should be either primary adenocarcinoma or squamous cell carcinoma of the lung.
- Patients are eligible for this study if their samples from CALGB 140202 are available.
- All living patients must sign the CALGB 151107 consent form to be eligible for this trial.
Exclusion
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT01414595
Start Date
March 1 2012
Last Update
June 27 2017
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
2
Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States, 19958
3
CCOP - Christiana Care Health Services
Newark, Delaware, United States, 19713
4
Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States, 21201